{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T06:32:18Z","timestamp":1770705138571,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T00:00:00Z","timestamp":1472083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T00:00:00Z","timestamp":1472083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Candida albicans (C. albicans<\/jats:italic>) is an important human commensal and opportunistic fungal pathogen. Secreted aspartyl proteinases (Saps) are a major virulence trait of <jats:italic>C. albicans<\/jats:italic>, and among these proteases Sap2 has the highest expression levels. It is possible that antibodies against Sap2 could provide an antifungal effect. In this study, two phages displaying anti-rSap2 single chain variable fragments (scFvs) were screened from human single fold scFv libraries, and their potential therapeutic roles were evaluated using a murine model infected by <jats:italic>C. albicans<\/jats:italic>. The <jats:italic>in vivo<\/jats:italic> efficacies were assessed by mortality rates, fungal burden and histological examination. Overall survival rates were significantly increased while the colony counts and infectious foci were significantly decreased after treatment with the scFv-phages relative to the control groups. In order to investigate the immune response provoked by scFv-phages, three kinds of cytokines (Th1, Th2 and Th17 types) were measured and a clear immune response was observed. These findings suggest that anti-rSap2 scFv-phages have potential in the therapy of systemic infection caused by <jats:italic>C. albicans<\/jats:italic>.<\/jats:p>","DOI":"10.1038\/srep32256","type":"journal-article","created":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T10:37:21Z","timestamp":1472121441000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Novel nanoscale bacteriophage-based single-domain antibodies for the therapy of systemic infection caused by Candida albicans"],"prefix":"10.1038","volume":"6","author":[{"given":"Shuai","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donghui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yicun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xintong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,25]]},"reference":[{"key":"BFsrep32256_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1128\/CMR.00029-06","volume":"20","author":"MA Pfaller","year":"2007","unstructured":"Pfaller, M. A. & Diekema, D. J. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20, 133\u2013163 (2007).","journal-title":"Clin. Microbiol. Rev."},{"key":"BFsrep32256_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.diagmicrobio.2012.02.001","volume":"73","author":"D Diekema","year":"2012","unstructured":"Diekema, D., Arbefeville, S., Boyken, L., Kroeger, J. & Pfaller, M. The changing epidemiology of healthcare-associated candidemia over three decades. Diagn. Microbiol. Infect. Dis. 73, 45\u201348 (2012).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"BFsrep32256_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1348-0421.2003.tb02783.x","volume":"47","author":"H Wakabayashi","year":"2003","unstructured":"Wakabayashi, H., Takakura, N., Teraguchi, S. & Tamura, Y. Lactoferrin feeding augments peritoneal macrophage activities in mice intraperitoneally injected with inactivated Candida albicans . Microbiol. Immunol. 47, 37\u201343 (2003).","journal-title":"Microbiol. Immunol."},{"key":"BFsrep32256_CR4","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1086\/599039","volume":"48","author":"DL Horn","year":"2009","unstructured":"Horn, D. L. et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin. Infect. Dis. 48, 1695\u20131703 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"BFsrep32256_CR5","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3201\/eid1210.060389","volume":"12","author":"S Chen","year":"2006","unstructured":"Chen, S. et al. Active surveillance for candidemia, Australia. Emerg. Infect. Dis. 12, 1508\u20131516 (2006).","journal-title":"Emerg. Infect. Dis."},{"key":"BFsrep32256_CR6","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1128\/JCM.00773-06","volume":"44","author":"AL Colombo","year":"2006","unstructured":"Colombo, A. L. et al. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J. Clin. Microbiol. 44, 2816\u20132823 (2006).","journal-title":"J. Clin. Microbiol."},{"key":"BFsrep32256_CR7","first-page":"1068","volume":"91","author":"L Pagano","year":"2006","unstructured":"Pagano, L. et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 91, 1068\u20131075 (2006).","journal-title":"Haematologica"},{"key":"BFsrep32256_CR8","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/cid\/cis697","volume":"55","author":"AA Cleveland","year":"2012","unstructured":"Cleveland, A. A. et al. Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008\u20132011. Clin. Infect. Dis. 55, 1352\u20131361 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"BFsrep32256_CR9","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1166\/jbn.2012.1374","volume":"8","author":"BP Damasceno","year":"2012","unstructured":"Damasceno, B. P. et al. Amphotericin B microemulsion reduces toxicity and maintains the efficacy as an antifungal product. J. Biomed. Nanotechnol. 8, 290\u2013300 (2012).","journal-title":"J. Biomed. Nanotechnol."},{"key":"BFsrep32256_CR10","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/nrmicro3156","volume":"11","author":"A Cassone","year":"2013","unstructured":"Cassone, A. Development of vaccines for Candida albicans: fighting a skilled transfromer. Nat. Rev. Microbiol. 11, 884\u2013891 (2013).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFsrep32256_CR11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.ijantimicag.2013.12.009","volume":"43","author":"S Liu","year":"2014","unstructured":"Liu, S. et al. Combination of fluconazole with non-antifungal agents: a promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery. Int. J. Antimicrob. Agents. 43, 395\u2013402 (2014).","journal-title":"Int. J. Antimicrob. Agents."},{"key":"BFsrep32256_CR12","doi-asserted-by":"publisher","first-page":"e403121","DOI":"10.1155\/2013\/403121","volume":"2013","author":"F Bugli","year":"2013","unstructured":"Bugli, F. et al. Human monoclonal antibody-based therapy in the treatment of invasive candidiasis. Clin. Dev. Immunol. 2013, e403121 (2013).","journal-title":"Clin. Dev. Immunol."},{"key":"BFsrep32256_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1586\/eri.11.152","volume":"10","author":"ID Jacobsen","year":"2012","unstructured":"Jacobsen, I. D. et al. Candida albicans dimorphism as a therapeutic target. Expert Rev. Anti Infect. Ther. 10, 85\u201393 (2012).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"BFsrep32256_CR14","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.drudis.2008.11.013","volume":"14","author":"K Gauwerky","year":"2009","unstructured":"Gauwerky, K., Borelli, C. & Korting, H. C. Targeting virulence: a new paradigm for antifungals. Drug Discov. Today 14, 214\u2013222 (2009).","journal-title":"Drug Discov. Today"},{"key":"BFsrep32256_CR15","first-page":"493","volume":"160","author":"DL Yamamura","year":"1999","unstructured":"Yamamura, D. L., Rotstein, C., Nicolle, L. E. & Ioannou, S. Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. CMAJ. 160, 493\u2013499 (1999).","journal-title":"CMAJ"},{"key":"BFsrep32256_CR16","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.actbio.2013.06.037","volume":"10","author":"R Farr","year":"2014","unstructured":"Farr, R., Choi, D. S. & Lee, S. W. Phage-based nanomaterials for biomedical applications. Acta Biomater. 10, 1741\u20131750 (2014).","journal-title":"Acta Biomater."},{"key":"BFsrep32256_CR17","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1128\/IAI.70.1.204-210.2002","volume":"70","author":"B Biswas","year":"2002","unstructured":"Biswas, B. et al. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium . Infect. Immun. 70, 204\u2013210 (2002).","journal-title":"Infect. Immun."},{"key":"BFsrep32256_CR18","doi-asserted-by":"publisher","first-page":"7724","DOI":"10.1158\/0008-5472.CAN-05-4441","volume":"66","author":"DN Krag","year":"2006","unstructured":"Krag, D. N. et al. Selection of tumor-binding ligands in cancer patients with phage display libraries. Cancer Res. 66, 7724\u20137733 (2006).","journal-title":"Cancer Res."},{"key":"BFsrep32256_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/abio.1996.0241","volume":"238","author":"JB Burritt","year":"1996","unstructured":"Burritt, J. B., Bond, C. W., Doss, K. W. & Jesaitis, A. J. Filamentous phage display of oligopeptide libraries. Anal. Biochem. 238, 1\u201313 (1996).","journal-title":"Anal. Biochem."},{"key":"BFsrep32256_CR20","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1099\/00221287-144-10-2731","volume":"144","author":"M Monod","year":"1998","unstructured":"Monod, M., Hube, B., Hess, D. & Sanglard, D. Differential regulation of SAP8 and SAP9, which encode two new members of the secreted aspartic proteinase family in Candida albicans . Microbiology. 144, 2731\u20132737 (1998).","journal-title":"Microbiology"},{"key":"BFsrep32256_CR21","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1128\/MMBR.67.3.400-428.2003","volume":"67","author":"JR Naglik","year":"2003","unstructured":"Naglik, J. R., Challacombe, S. J. & Hube, B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol. Mol. Biol. Rev. 67, 400\u2013428 (2003).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"BFsrep32256_CR22","doi-asserted-by":"publisher","first-page":"7061","DOI":"10.1128\/IAI.73.10.7061-7063.2005","volume":"73","author":"BN Taylor","year":"2005","unstructured":"Taylor, B. N. et al. Induction of SAP7 correlates with virulence in an intravenous infection model of candidiasis but not in a vaginal infection model in mice. Infect. Immun. 73, 7061\u20137063 (2005).","journal-title":"Infect. Immun."},{"key":"BFsrep32256_CR23","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1074\/jbc.M509297200","volume":"281","author":"A Albrecht","year":"2006","unstructured":"Albrecht, A. et al. Glycosylphosphatidylinositol-anchored proteases of Candida albicans target proteins necessary for both cellular processes and host-pathogen interactions. J. Biol. Chem. 281, 688\u2013694 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFsrep32256_CR24","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1046\/j.1365-2958.2000.02132.x","volume":"38","author":"A Schweizer","year":"2000","unstructured":"Schweizer, A., Rupp, S., Taylor, B. N., R\u00f6llinghoff, M. & Schr\u00f6ppel, K. The TEA\/ATTS transcription factor CaTec1p regulates hyphal development and virulence in Candida albicans . Mol. Microbiol. 38, 435\u2013445 (2000).","journal-title":"Mol. Microbiol."},{"key":"BFsrep32256_CR25","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1128\/IAI.68.6.3172-3179.2000","volume":"68","author":"L de Repentigny","year":"2000","unstructured":"de Repentigny, L., Aumont, F., Bernard, K. & Belhumeur, P. Characterization of binding of Candida albicans to small intestinal mucin and its role in adherence to mucosal epithelial cells. Infect. Immun. 68, 3172\u20133179 (2000).","journal-title":"Infect. Immun."},{"key":"BFsrep32256_CR26","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/j.1462-5822.2004.00439.x","volume":"6","author":"J Naglik","year":"2004","unstructured":"Naglik, J., Albrecht, A., Bader, O. & Hube, B. Candida albicans proteinases and host\/pathogen interactions. Cell. Microbiol. 6, 915\u2013926 (2004).","journal-title":"Cell. Microbiol."},{"key":"BFsrep32256_CR27","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1128\/iai.65.9.3529-3538.1997","volume":"65","author":"B Hube","year":"1997","unstructured":"Hube, B. et al. Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence. Infect. Immun. 65, 3529\u20133538 (1997).","journal-title":"Infect. Immun"},{"key":"BFsrep32256_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.bcp.2014.05.020","volume":"90","author":"A Jebali","year":"2014","unstructured":"Jebali, A. et al. Triangular gold nanoparticles conjugated with peptide ligands: a new class of inhibitor for Candida albicans secreted aspartyl proteinase. Biochem. Pharmacol. 90, 349\u2013355 (2014).","journal-title":"Biochem. Pharmacol."},{"key":"BFsrep32256_CR29","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1021\/bc500173f","volume":"25","author":"HY Kim","year":"2014","unstructured":"Kim, H. Y., Wang, X., Wahlberg, B. & Edwards, W. B. Discovery of hapten-specific scFv from a phage display library and applications for HER2-positive tumor imaging. Bioconjug. Chem. 25, 1311\u20131322 (2014).","journal-title":"Bioconjug. Chem."},{"key":"BFsrep32256_CR30","doi-asserted-by":"publisher","first-page":"e980250","DOI":"10.1155\/2012\/980250","volume":"2012","author":"ZA Ahmad","year":"2012","unstructured":"Ahmad, Z. A. et al. scFv antibody: principles and clinical application. Clin. Dev. Immunol. 2012, e980250 (2012).","journal-title":"Clin. Dev. Immunol."},{"key":"BFsrep32256_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1089\/hyb.2007.007","volume":"26","author":"JA Rodrigues","year":"2007","unstructured":"Rodrigues, J. A., H\u00f6fling, J. F., Azevedo, R. A., Gabriel, D. L. & Tamashiro, W. M. Production of monoclonal antibodies for detection of a secreted aspartyl proteinase from Candida spp. in biologic specimens. Hybridoma. 26, 201\u2013210 (2007).","journal-title":"Hybridoma"},{"key":"BFsrep32256_CR32","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1365-2567.2004.01819.x","volume":"111","author":"M Vilanova","year":"2004","unstructured":"Vilanova, M. et al. Protection against systemic candidiasis in mice immunized with secreted aspartic proteinase 2. Immunology 111, 334\u2013342 (2004).","journal-title":"Immunology"},{"key":"BFsrep32256_CR33","doi-asserted-by":"publisher","first-page":"e00724","DOI":"10.1128\/mBio.00724-15","volume":"6","author":"E Pericolini","year":"2015","unstructured":"Pericolini, E. et al. Secretory aspartyl proteinases cause vaginitis and can mediate vaginitis caused by Candida albicans in mice. MBio 6, e00724 (2015).","journal-title":"MBio"},{"key":"BFsrep32256_CR34","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1002\/adhm.201500930","volume":"5","author":"Y Huai","year":"2016","unstructured":"Huai, Y. et al. Genetically engineered virus nanofibers as an efficient vaccine for preventing fungal infection. Adv. Healthc. Mater. 5, 786\u2013794 (2016).","journal-title":"Adv. Healthc. Mater."},{"key":"BFsrep32256_CR35","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/infdis\/jit534","volume":"209","author":"N Tarumoto","year":"2014","unstructured":"Tarumoto, N. et al. Exacerbation of invasive Candida albicans infection by commensal bacteria or a glycolipid through IFN-\u03b3 produced in part by iNKT cells. J. Infect. Dis. 209, 799\u2013810 (2014).","journal-title":"J. Infect. Dis."},{"key":"BFsrep32256_CR36","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nri2939","volume":"11","author":"L Romani","year":"2011","unstructured":"Romani, L. Immunity to fungal infections. Nat. Rev. Immunol. 11, 275\u2013288 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"BFsrep32256_CR37","doi-asserted-by":"publisher","first-page":"e1242","DOI":"10.1038\/srep01242","volume":"3","author":"J Wang","year":"2013","unstructured":"Wang, J., Wang, L., Li, X. & Mao, C. Virus activated artificial ECM induces the osteoblastic differentiation of mesenchymal stem cells without osteogenic supplements. Sci. Rep. 3, e1242 (2013).","journal-title":"Sci. Rep."},{"key":"BFsrep32256_CR38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/mmy.39.1.41.50","volume":"39","author":"TR Traynor","year":"2001","unstructured":"Traynor, T. R. & Huffnagle, G. B. Role of chemokines in fungal infections. Med. Mycol. 39, 41\u201350 (2001).","journal-title":"Med. Mycol."},{"key":"BFsrep32256_CR39","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1128\/IAI.01085-13","volume":"82","author":"JB Mear","year":"2014","unstructured":"Mear, J. B. et al. Candida albicans airway exposure primes the lung innate immune response against Pseudomonas aeruginosa infection through innate lymphoid cell recruitment and interleukin-22-associated mucosal response. Infect. Immun. 82, 306\u2013315 (2014).","journal-title":"Infect. Immun."},{"key":"BFsrep32256_CR40","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/eji.201242605","volume":"42","author":"S Cypowyj","year":"2012","unstructured":"Cypowyj, S., Picard, C., Mar\u00f3di, L., Casanova, J. L. & Puel, A. Immunity to infection in IL-17-deficient mice and humans. Eur. J. Immunol. 42, 2246\u20132254 (2012).","journal-title":"Eur. J. Immunol."},{"key":"BFsrep32256_CR41","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.4161\/hv.27714","volume":"10","author":"Y Wang","year":"2014","unstructured":"Wang, Y. et al. Hybrid phage displaying SLAQVKYTSASSI induces protection against Candida albicans challenge in BALB\/c mice. Hum. Vaccin. Immunother. 10, 1057\u20131063 (2014).","journal-title":"Hum. Vaccin. Immunother"},{"key":"BFsrep32256_CR42","doi-asserted-by":"publisher","first-page":"243","DOI":"10.4103\/0377-4929.120377","volume":"56","author":"Y Wang","year":"2013","unstructured":"Wang, Y. et al. Detection of Candida albicans Sap2 in cancer patient serum samples by an indirect competitive enzyme-linked immunosorbent assay for the diagnosis of candidiasis. Indian J. Pathol. Microbiol. 56, 243\u2013247 (2013).","journal-title":"Indian J. Pathol. Microbiol."},{"key":"BFsrep32256_CR43","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.toxicon.2010.03.005","volume":"55","author":"E Garet","year":"2010","unstructured":"Garet, E., Cabado, A. G., Vieites, J. M. & Gonz\u00e1lez-Fern\u00e1ndez, A. Rapid isolation of single-chain antibodies by phage display technology directed against one of the most potent marine toxins: Palytoxin. Toxicon 55, 1519\u20131526 (2010).","journal-title":"Toxicon"},{"key":"BFsrep32256_CR44","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2217\/fmb.11.72","volume":"6","author":"FM Klis","year":"2011","unstructured":"Klis, F. M., de Koster, C. G. & Brul, S. A mass spectrometric view of the fungal wall proteome. Future Microbiol. 6, 941\u2013951 (2011).","journal-title":"Future Microbiol."},{"key":"BFsrep32256_CR45","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1128\/iai.58.10.3319-3324.1990","volume":"58","author":"BJ Kullberg","year":"1990","unstructured":"Kullberg, B. J., van \u2018t Wout, J. W. & van Furth, R. Role of granulocytes in increased host resistance to Candida albicans induced by recombinant interleukin-1. Infect. Immun. 58, 3319\u20133324 (1990).","journal-title":"Infect. Immun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep32256.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep32256","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep32256.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T06:03:47Z","timestamp":1672898627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep32256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,25]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,8,31]]}},"alternative-id":["BFsrep32256"],"URL":"https:\/\/doi.org\/10.1038\/srep32256","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,25]]},"assertion":[{"value":"8 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32256"}}